Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioPharmX

0.5100
0.0000
Volume:- -
Turnover:- -
Market Cap:9.32M
PE:-0.68
High:0.5100
Open:0.5100
Low:0.5100
Close:0.5100
Loading ...

Company Profile

Company Name:
BioPharmX
Exchange:
AMEX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
BioPharmX Corporation, a specialty pharmaceutical company, develops products for the treatment of dermatologic conditions using its proprietary HyantX topical delivery system. Its clinical-stage product candidates include BPX01, a topical antibiotic gel that has completed Phase IIb clinical trials for the treatment of inflammatory lesions of acne; and BPX04, a topical antibiotic, which is in Phase IIb study for the treatment of inflammatory lesions of papulopustular rosacea. The company serves pharmaceutical companies, physician's practices, dermatologists, and general practitioners. BioPharmX Corporation is headquartered in Campbell, California.